CSBR (STOCKS)
Champions Oncology, Inc.
$5.900000
-0.220000 (-3.59%)
Prev close: $6.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert Brainin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $81.93M
- Employees
- 306
- P/E (TTM)
- 35.46
- P/B (TTM)
- 19.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$0.02 | $0.01 | +0.0098 | +96.08% |
|
Sep 2025 (Q1)
|
$0.02 | $-0.01 | +0.0302 | +296.08% |
|
Jun 2025 (Q4)
|
$-0.07 | $-0.20 | +0.1340 | +65.69% |
|
Mar 2025 (Q3)
|
$0.36 | $-0.01 | +0.3702 | +3,629.41% |
Financial Statements
| Revenues | $58.42M |
| Benefits Costs and Expenses | $56.07M |
| Cost Of Revenue | $29.15M |
| Costs And Expenses | $56.07M |
| Gross Profit | $29.28M |
| Operating Expenses | $27.13M |
| Depreciation and Amortization | $1.51M |
| Research and Development | $8.38M |
| Other Operating Expenses | $17.64M |
| Operating Income/Loss | $2.15M |
| Income/Loss From Continuing Operations After Tax | $2.43M |
| Income/Loss From Continuing Operations Before Tax | $2.36M |
| Income Tax Expense/Benefit | -$74.00K |
| Net Income/Loss | $2.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$61.00K |
| Net Income/Loss Attributable To Parent | $2.49M |
| Net Income/Loss Available To Common Stockholders, Basic | $2.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.18 |
| Diluted Earnings Per Share | $0.17 |
| Basic Average Shares | 41,320,054 |
| Diluted Average Shares | 28,257,688 |
| Assets | $30.16M |
| Current Assets | $21.33M |
| Noncurrent Assets | $8.83M |
| Liabilities | $25.93M |
| Current Liabilities | $22.14M |
| Accounts Payable | $5.99M |
| Other Current Liabilities | $16.15M |
| Noncurrent Liabilities | $3.79M |
| Equity | $4.23M |
| Equity Attributable To Noncontrolling Interest | $61.00K |
| Equity Attributable To Parent | $4.17M |
| Liabilities And Equity | $30.16M |
| Net Cash Flow From Operating Activities | $6.22M |
| Net Cash Flow From Operating Activities, Continuing | $6.22M |
| Net Cash Flow From Investing Activities | -$583.00K |
| Net Cash Flow From Investing Activities, Continuing | -$583.00K |
| Net Cash Flow From Financing Activities | $122.00K |
| Net Cash Flow From Financing Activities, Continuing | $122.00K |
| Net Cash Flow | $5.76M |
| Net Cash Flow, Continuing | $5.76M |
| Comprehensive Income/Loss | $2.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.43M |
| Other Comprehensive Income/Loss | $0.00 |